Insight into binding of phosphodiesterase-9A selective inhibitors by crystal structures and mutagenesis.
Insight into binding of phosphodiesterase-9A selective inhibitors by crystal structures and mutagenesis.
复制标题
DOI:
10.1021/jm901519f
复制
发表时间:
2010-02-25
影响因子:
7.3
通讯作者:
Ke H
中科院分区:
文献类型:
--
作者:
Wang H;Luo X;Ye M;Hou J;Robinson H;Ke H
PDE9 inhibitors have been studied as therapeutics for treatment of cardiovascular diseases, diabetes, and neurodegenerative disorders. To illustrate the inhibitor selectivity, the crystal structures of the PDE9A catalytic domain in complex with the enantiomers of PDE9 inhibitor 1-(2-chlorophenyl)-6-(3,3,3-trifluoro-2-methylpropyl)-1H-pyrazolo[3,4-d]pyrimidine-4(5H)-one ((R)-BAY73-6691 or (S)-BAY73-6691, 1r or 1s) were determined and mutagenesis was performed. The structures showed that the fluoromethyl groups of 1r and 1s had different orientations while the other parts of the inhibitors commonly interacted with PDE9A. These differences may explain the slightly different affinity of 1r (IC50 = 22 nM) and 1s (IC50 = 88 nM). The mutagenesis experiments revealed that contribution of the binding residues to the inhibitor sensitivity varies dramatically, from a few of folds to three orders of magnitude. On the basis of the crystal structures, a hypothesized compound that simulates the recently published PDE9 inhibitors was modeled to provide insight into the inhibitor selectivity.
登录
查看更多内容
DOI:
10.1126/science.1152506
发表时间:
2008-05-16
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
O'Neill JS;Maywood ES;Chesham JE;Takahashi JS;Hastings MH
通讯作者:
Hastings MH
影响因子:
4.1
作者:
Diederen, R. M. H.;La Heij, E. C.;de Vente, J.
通讯作者:
de Vente, J.
影响因子:
2.9
作者:
Huai, Q;Colicelli, J;Ke, HM
通讯作者:
Ke, HM
影响因子:
2.7
作者:
DeNinno, Michael P.;Andrews, Melissa;Gibbs, E. Michael
通讯作者:
Gibbs, E. Michael
DOI:
10.1073/pnas.0708850105
发表时间:
2008-09-09
影响因子:
11.1
作者:
Liu, Shenping;Mansour, Mahmoud N.;Menniti, Frank S.
通讯作者:
Menniti, Frank S.